Protagonist Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Protagonist Therapeutics Inc
CIK #0001377121
EDGAR Form CIK 2011 - 2026
10-K [0001377121]
10-Q [0001377121]
3 [0001377121]
4 [0001377121]
5 [0001377121]
8-K [0001377121]
D [0001377121]
SC 13D [0001377121]
SC 13G [0001377121]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Protagonist Therapeutics Inc [2026-05-12]
Vanguard Capital Management LLC Protagonist Therapeutics Inc [2026-04-30]
Vanguard Portfolio Management LLC Protagonist Therapeutics Inc [2026-04-29]
Wellington Management Group LLP Protagonist Therapeutics Inc [2026-02-10]
State Street Corp Protagonist Therapeutics Inc [2025-08-11]
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2025-06-16]
State Street Corp Protagonist Therapeutics Inc [2025-05-13]
Deep Track Capital LP Protagonist Therapeutics Inc [2025-04-10]
State Street Corp Protagonist Therapeutics Inc [2024-10-16]
Point72 Asset Management LP Protagonist Therapeutics Inc [2023-12-18]
View All
Form 3/4/5 Subject 2011 - 2026
Waddill William D
Protagonist Therapeutics Inc
Patel Dinesh V Ph D
Giraudo Bryan
Ali Asif
Molina Arturo MD
Selick Harold E
Williams Lewis T
O'Dowd Sarah A
Gupta Suneel
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 24,000 $0.00
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 15,000 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Option exercise 5,265 $12.17 64,075
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Sell 24,765 $104.24 2,581,504
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 19,500 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Sell 15,000 $104.79 1,571,850
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Option exercise 15,000 $8.04 120,600
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Option exercise 24,000 $12.88 309,120
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Option exercise 19,500 $19.19 374,205
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 5,265 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-26 Sell 24,000 $105.00 2,520,000
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-25 Option exercise 54,641 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-25 Sell 54,641 $101.00 5,518,741
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-25 Option exercise 54,641 $8.58 468,820
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-24 Option exercise 59 $8.58 506
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-24 Sell 59 $101.00 5,959
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
2026-03-24 Option exercise 59 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-03-23 Gift 50,000 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2026-02-17 Option exercise 18,000 $10.84 195,120
Protagonist Therapeutics Inc PTGX
Common Stock
2026-02-17 Sell 18,000 $82.42 1,483,560
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com